Secretome Analysis of Host Cells Infected with Toxoplasma gondii after Treatment of Human Epidermal Growth Factor Receptor 2/4 Inhibitors
The Korean Journal of Parasitology. 2020;58(3):249-255 
Serum Response Factor Regulates Immediate Early Host Gene Expression in Toxoplasma gondii-Infected Host Cells
PLoS ONE. 2011;6(3):e18335
Acquired trichomegaly and hypertrichosis after treatment with epidermal growth factor receptor inhibitors
Acta Ophthalmologica. 2014;92:0-0
Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy
Cells. 2018;7(11):212
Influence of Nitrofurantoin on Toll-Like Receptor Pathway in Human Trophoblastic Cells (Bewo) Infected with Toxoplasma Gondii
. 2022;
The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
Cancers. 2011;3(2):2667-2678
Advances in Therapy for Hormone Receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer Patients Who Have Experienced Progression After Treatment with CDK4/6 Inhibitors
OncoTargets and Therapy. 2021;Volume 14:2929-2939
Epidermal Growth Factor Receptor (EGFR) Inhibitors
Encyclopedia of Cancer. 2017;1565-1565
Epidermal growth factor receptor promotes cerebral and retinal invasion by Toxoplasma gondii
Scientific Reports. 2019;9(1):
Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Adjuvant Setting for Patients with Resected Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer: A Meta-Analysis with 11 Trials
Oncology Research and Treatment. 2021;44(6):344-353